The world's scientific and social network for malaria professionals
Subscribe to free Newsletter | 10732 malaria professionals are enjoying the free benefits of MalariaWorld today

Asymmetrical dimethylarginine (ADMA)

Open Access | Increased Asymmetric Dimethylarginine in Severe Falciparum Malaria: Association with Impaired Nitric Oxide Bioavailability and Fatal Outcome

April 27, 2010 - 13:44 -- Kabogo Ndegwa
Author(s): 
Tsin W. Yeo, Daniel A. Lampah, Nicholas M. Anstey,. et al
Reference: 
PLoS Pathog 6(4): e1000868

Asymmetrical dimethylarginine (ADMA), an endogenous inhibitor of nitric oxide synthase (NOS), is a predictor of mortality in critical illness. Severe malaria (SM) is associated with decreased NO bioavailability, but the contribution of ADMA to the pathogenesis of impaired NO bioavailability and adverse outcomes in malaria is unknown.

Person: 
Medical Condition: 
Subscribe to RSS - Asymmetrical dimethylarginine (ADMA)